Search
AngioDynamics Inc
ANGOAdd to Watchlist
13.090USD
+0.010+0.08%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
545.62MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.08%
5 Days
-2.31%
1 Month
+9.63%
6 Months
-1.06%
Year to Date
+1.95%
1 Year
+36.64%
Key Figures
13.250Open
13.400High
350.28KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.84%Turnover Ratio
13.080Prev. Close
12.932Low
3.37MTurnover
LossP/E Static
3.15P/B
0.00%Div Yield TTM
-11.50%ROA
13.99052wk High
1.36Volume Ratio
-33.99MNet Profit
41.68MShares
-0.7584EPS TTM
0.39Beta
-17.47%ROE
8.36052wk Low
3.58%Amplitude
49.49%Gross Margin
545.62MMarket Cap
3.29Reward/Risk
2.65%Risk Rate
TradingKey Stock Score of AngioDynamics Inc
Currency: USD Updated: 2026-07-02Key Insights
AngioDynamics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.67.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AngioDynamics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
AngioDynamics Inc Highlights
StrengthsRisks
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Undervalued
The company’s latest PE is -17.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.82M shares, decreasing 15.68% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 1.47M shares of this stock.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
18.667
Target Price
+42.60%
Upside Space
AngioDynamics Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AngioDynamics Inc Info
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Ticker SymbolANGO
CompanyAngioDynamics Inc
CEOClemmer (James C)
Websitehttps://www.angiodynamics.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52925.500
+72.600 (+0.14%)
29556.900
-113.000 (-0.38%)
7504.900
-2.900 (-0.04%)
15066.000
+103.000 (+0.69%)
69364.000
-312.000 (-0.45%)
6414.800
+2.400 (+0.04%)
68.534
-0.149 (-0.22%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4185.310
+10.700 (+0.26%)
FAQs
What is the current price of AngioDynamics Inc (ANGO)?
The current price of AngioDynamics Inc (ANGO) is 13.09.
What is the symbol of AngioDynamics Inc?
The ticker symbol of AngioDynamics Inc is ANGO.
What is the 52-week high of AngioDynamics Inc?
The 52-week high of AngioDynamics Inc is 13.99.
What is the 52-week low of AngioDynamics Inc?
The 52-week low of AngioDynamics Inc is 8.36.
What is the market capitalization of AngioDynamics Inc?
The market capitalization of AngioDynamics Inc is 545.62M.
Is AngioDynamics Inc (ANGO) currently rated as Buy, Hold, or Sell?
According to analysts, AngioDynamics Inc (ANGO) has an overall rating of Buy, with a price target of 18.67.
What is the Earnings Per Share (EPS TTM) of AngioDynamics Inc (ANGO)?
The Earnings Per Share (EPS TTM) of AngioDynamics Inc (ANGO) is -0.83.